Commentary · 21 Feb 2026
Conference abstractPublished 21 Oct 2013
The antitumor effect of a polysaccharide from Strongylocentrotus nudus eggs (SEP) is mediated by stimulating cytotoxic lymphocytes in vivo
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
SEP, a polysaccharide isolated from Strongylocentrotus nudus eggs, is a D-glucan containing an α-1,4-linked backbone and α-1,6-linked branches. SEP showed obvious antitumor effects against H22 hepatocellular carcinoma, Lewis Lung cancer (LLC) and human non-small-cell-lung-cancer (NSCLC) in mice. The obtained results indicated that SEP had no inhibitory effect on cancer cells in vitro , indicating that its antitumor effect may be related to immunomodulation. In tumor-bearing mice, SEP could not only remarkably enhance splenocyte proliferation, CD4 + and CD8 + T cell numbers as well as cytotoxic lymphocytes (CTLs) activity, natural killer (NK) cell cytotoxity, but also elevated IL-2 and TNF-α secretion as well as IgA, IgM and IgG levels in the serum. In addition, SEP significantly induced Erk phosphorylation and Akt phosphorylation in mouse splenocytes. The transcriptional activity of NFAT in Jurkat T cells was promoted after SEP treatment, indicating that SEP enhanced the transcription and expression of downstream gene IL-2. Pre-incubation with TLR2 and TLR4 blocking antibodies inhibited SEP- induced splenocyte proliferation and IL-2 secretion. Interestingly, the inhibition of H460 growth induced by SEP in nude mice was abrogated by selective depletion of the NK cell population in mice. In conclusion, our study demonstrates that SEP effectively inhibits tumor growth in vivo via enhancement of host immune system function, including enhancing the activity of CTLs and NK cells, indicating that SEP could function as a potential immunotherapy drug for cancer therapy.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Mengyun Ke”
